Aemetis, Inc. — 2012 Form 10-K Summary
Business context and reporting period
Annual report for the fiscal year ended December 31, 2012; it is not a standalone quarterly filing. Aemetis produces renewable fuels and specialty chemicals, operating an ethanol plant in Keyes, California, and a biodiesel plant in Kakinada, India. The Keyes facility was acquired in July 2012; the India facility also processes and sells refined glycerin and palm oil.
Financial and operating results
| Metric | 2012 | 2011 |
|---|---|---|
| Revenue | $189.0 million | $141.9 million |
| Gross profit (loss) | ($8.9 million); margin about (4.7%) | $4.6 million; margin about 3.3% |
| Operating loss | ($21.2 million) | ($4.5 million) |
| Net loss | ($4.3 million) | ($18.3 million) |
| Operating cash flow | ($16.9 million) | ($1.2 million) |
| Cash at year-end | $0.29 million | $0.25 million |
| Total debt | $70.0 million | $29.6 million |
2012 revenue rose about 33%, principally because Keyes operated for a full year rather than nine months. The improvement in reported net loss largely reflects a $42.3 million bargain-purchase gain on the Cilion acquisition; it does not indicate improved underlying operations. Results also included $17.7 million of interest expense and a $9.1 million debt-extinguishment loss.
North America revenue was $175.5 million, but segment gross loss was $8.3 million. Ethanol sold rose 42% to 53.0 million gallons, while average selling price fell 14% to $2.50 per gallon. India revenue was $13.5 million, with a segment gross loss of $0.6 million. Biodiesel sales fell 52% to 4,127 metric tons; sales mix shifted toward refined palm oil and refined glycerin.
Liquidity was severely constrained: current assets were $6.8 million versus current liabilities of $57.8 million, negative working capital was $51.0 million, and the current ratio was 0.13. Financing activities provided $33.3 million in cash, largely offsetting operating and investing outflows. The auditor issued an unmodified opinion on the financial statements but emphasized substantial doubt about the company’s ability to continue as a going concern.
Material changes versus 2011
- Gross results turned from profit to loss, and operating loss increased substantially.
- Debt more than doubled, largely in connection with the Keyes acquisition and related financing; current liabilities rose sharply.
- Keyes production increased, but weaker ethanol economics contributed to negative margins. The plant averaged 96% of nameplate capacity during 2012, versus 101% during its nine operating months in 2011.
- India biodiesel sales declined, including because 2011 had a nonrecurring European order. New refining units supported higher refined glycerin and palm-oil sales.
- Year-end common shares outstanding were 180.3 million, up from 130.7 million; debt conversions, acquisition consideration, and other stock issuances contributed to the increase.
Outlook, risks, contingencies, and unusual items
- Keyes was idled on January 15, 2013 because of unfavorable corn-ethanol margins. Management planned a restart using sorghum (milo), biogas, corn, or a mix depending on economics. The filing gives inconsistent timing: it refers to a restart in late April 2013 in one section, but says April 2014 in a note. Verify the intended date.
- Management expected India’s 2013 diesel-price increases and resumed European biodiesel shipments to improve margins, but these were forward-looking expectations, not assured outcomes. India’s biodiesel pricing is linked to government-set diesel prices.
- The company depended on additional financing and working-capital support from Third Eye Capital, J.D. Heiskell, and Secunderabad Oils. Third Eye debt carried high interest and restrictive covenants; at year-end, $52.2 million of Third Eye financing arrangements was outstanding. The filing reports subsequent waivers, fee obligations, collateral pledges, and additional borrowing arrangements.
- The India subsidiary was in default on its State Bank of India loan. The bank sought recovery through a legal proceeding; the filing describes potential enforcement against company property and continuing default interest.
- Other notable items include a $2.25 million UBS settlement related to the Cilion merger, accrued at year-end, and a $42.3 million provisional bargain-purchase gain. The acquisition allocation was not finalized.
- Management reported ineffective disclosure controls and internal control over financial reporting, citing staffing limitations, spreadsheet reliance, and weaknesses in accounting for complex transactions. Remediation was ongoing.
- Key risks include ongoing losses and negative cash flow, commodity-price exposure, customer and working-capital-provider concentration, debt maturities and defaults, regulatory changes, environmental liabilities, and potential dilution. The common stock traded sporadically on the OTC market.
Most important facts for investors to verify
- Whether the Keyes plant restarted, when it did so, and whether production achieved positive cash margins.
- Available liquidity, current lender commitments, debt balances and maturities, covenant compliance, and status of the State Bank of India dispute.
- Whether expected India diesel-price changes and European sales translated into sustained positive operating margins.
- The final Cilion purchase-price allocation and the nonrecurring nature of the bargain-purchase gain in reported earnings.
- Progress in remediating material weaknesses and the company’s ability to fund operations without further asset sales or significant share issuance.